Follicular Thyroid Cancer

• CLINICAL_TRIALS research · 2026-04-20
  Clinical Trial Update: Studies on Tumors of the Thyroid

  National Institute of Diabetes and Digestive and Kidney Diseases is recruiting for thyroid tumor studies spanning multiple thyroid cancer su…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer

  This clinical trial update investigates the correlation between urinary exosomal protein biomarkers and pathological manifestations in thyro…

• CLINICAL_TRIALS trial_result · 2025-10-07
  Clinical Trial Update: PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer [Phase 2]

  Phase 2 clinical trial evaluating PDR001 in combination therapy for radioiodine-refractory thyroid cancer is active but not recruiting.

• CLINICAL_TRIALS trial_result · 2025-02-28
  Clinical Trial Update: Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers [Phase 1]

  Phase 1 trial evaluating the combination of vemurafenib and copanlisib in radioiodine-refractory thyroid cancers has completed with results …

• CLINICAL_TRIALS research · 2024-12-16
  Clinical Trial Update: Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)

  This document describes the development and validation of a robotic thyroidectomy competency assessment score (RTAS) for robot-assisted thyr…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-05-31
  Clinical Trial Update: Long-term Survival Outcomes of Total Thyroidectomy and Radioactive Iodine Therapy in Unilateral T3/T4 FTC

  This clinical trial reports long-term survival outcomes for patients with unilateral T3/T4 follicular thyroid cancer treated with total thyr…

• CLINICAL_TRIALS trial_result · 2021-01-22
  Clinical Trial Update: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer [Phase 2]

  Phase 2 adaptive TKI therapy trial in thyroid cancer was terminated; results posted previously.

• CLINICAL_TRIALS trial_result · 2018-04-18
  Clinical Trial Update: Sutent Adjunctive Treatment of Differentiated Thyroid Cancer [Phase 2]

  Phase 2 trial evaluating Sutent as adjunctive therapy for differentiated thyroid cancer has completed with results posted.

• CLINICAL_TRIALS trial_result · 2017-04-25
  Clinical Trial Update: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer [Phase 2]

  A Phase 2 trial evaluating sunitinib malate for iodine-refractory recurrent or metastatic thyroid cancer has completed enrollment and posted…

• CLINICAL_TRIALS trial_result · 2015-11-05
  Clinical Trial Update: Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery [Phase 1]

  Phase 1 study evaluating the combination of Iodine-131 and Pazopanib in patients with recurrent or metastatic thyroid cancer that cannot be …

• CLINICAL_TRIALS trial_result · 2014-09-01
  Clinical Trial Update: Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 [Phase 2]

  Phase 2 clinical trial evaluating decitabine in iodine-refractory metastatic papillary or follicular thyroid cancer completed with results p…

• CLINICAL_TRIALS trial_result · 2014-06-25
  Clinical Trial Update: Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy [Phase 2]

  Phase 2 trial evaluating bortezomib in metastatic thyroid cancer patients non-responsive to radioactive iodine; study completed with results…

• CLINICAL_TRIALS trial_result · 2014-05-06
  Clinical Trial Update: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer [Phase 2]

  Phase 2 trial of tanespimycin in patients with inoperable locoregionally advanced or metastatic thyroid cancer has completed with results po…

• CLINICAL_TRIALS trial_result · 2014-01-16
  Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer [Phase 2]

  Phase 2 trial of sorafenib tosylate in locally advanced, metastatic, or locally recurrent thyroid cancers was terminated.

• CLINICAL_TRIALS trial_result · 2013-12-19
  Clinical Trial Update: Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine [Phase 2]

  Phase 2 trial evaluating romidepsin in patients with recurrent and/or metastatic thyroid cancer not responding to radioactive iodine; result…